“Hepatic Adverse Effects and Genetic Polymorphisms of NAT2 and CYP2C9”. Precision Medicine Communications 1, no. 1 (December 30, 2021): 05–07. Accessed May 8, 2026. https://rootspress.org/journals/index.php/PMC/article/view/72.